Clinical trial

The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome

NCT00001343 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed

Key facts

NCT number NCT00001343
Title The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome
Official title The Relative Effects of Androgen, Estrogen, and the Combination of Androgen and Estrogen on Growth Rate, GH Binding Protein, IGF-I, and Cognitive Function in Growth Hormone-Treated Girls With Turner Syndrome
Lead sponsor Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Dwarfism, Turner's Syndrome
Intervention type Drug
Interventions Humatrope, Oxandrolone
Enrollment 80
Start date Dec 11, 1992
Completion Oct 10, 2007
First posted Nov 4, 1999
Last update posted Jul 2, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies